HGS1006

· Human Genome Sciences, a GSK Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HGS1006, covering 2016-03-28 to 2018-01-16. Get the full timeline:

Most recent: Clinical Trial Update: A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057 [Phase 3]